Wednesday, November 12, 2008

Anti-obesity drug use suspended

More malpractice news about the malpractice known as diet drugs.
"The European drugs watchdog is recommending doctors do not prescribe the anti-obesity drug rimonabant, also known as Acomplia.

The European Medicines Agency has said the risk of serious psychiatric problems and even suicide are too high."
Really, it is better to lose the pounds without the twin malpractices of drugs and surgery.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.